Cargando…

How Biomarker-Based Diagnosis and Treatment Affect Alzheimer’s Stigma: Results of a Randomized Trial

Alzheimer’s disease (AD) causes progressive disability and, ultimately, death. Currently no therapy can delay or slow cognitive and functional decline. This prognosis contributes to the general public’s negative reactions—discrimination, pity, and social distance—toward individuals with AD and their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stites, Shana, Gill, Jeanine, Largent, Emily, Harkins, Kristin, Krieger, Abba, Karlawish, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682712/ http://dx.doi.org/10.1093/geroni/igab046.926

Ejemplares similares

Effects of Self-Identification as a Caregiver on Expectations of Public Stigma of Alzheimer’s Disease
por: Stites, Shana D., et al.
Publicado: (2021)

Gender Differences in How the American Public Reacts to a Person With Mild-Stage Dementia
por: Stites, Shana, et al.
Publicado: (2020)

‘That would be dreadful’: The ethical, legal, and social challenges of sharing your Alzheimer’s disease biomarker and genetic testing results with others
por: Largent, Emily A, et al.
Publicado: (2021)

What is paradoxical lucidity? The answer begins with its definition
por: Peterson, Andrew, et al.
Publicado: (2021)

IS THERE A DIFFERENCE BETWEEN TERMINAL LUCIDITY AND PARADOXICAL LUCIDITY?
por: Peterson, Andrew, et al.
Publicado: (2022)

Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease
por: Stites, Shana D., et al.
Publicado: (2018)

The CoGenT3 Study: Examining Gender’s Impact on Education and Cognition Trends in Three American Generations
por: Stites, Shana, et al.
Publicado: (2020)

Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results
por: Largent, Emily A., et al.
Publicado: (2020)

Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
por: Largent, Emily A., et al.
Publicado: (2018)

A systematic review of measures of gender and biological sex: Exploring candidates for Alzheimer's disease and related dementias (AD/ADRD) research
por: Stites, Shana D., et al.
Publicado: (2023)

Reactions to learning a “not elevated” amyloid PET result in a preclinical Alzheimer’s disease trial
por: Grill, Joshua D., et al.
Publicado: (2018)

Patterns Among Same-Sex Spousal Couples: Diverse Sociocultural Representation in Alzheimer’s Research
por: Stites, Shana
Publicado: (2021)

Response to “Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure”
por: Grill, Joshua D., et al.
Publicado: (2019)

Assessing SSDoH in Alzheimer's Research: Core Measures and Those in Sexual and Gender Minority Populations
por: Stites, Shana, et al.
Publicado: (2021)

Toward a Model for Measuring Social and Structural Determinants of Alzheimer’s Disease and Related Dementias
por: Stites, Shana, et al.
Publicado: (2021)

How does stigma affect people with psoriasis?
por: Łakuta, Patryk, et al.
Publicado: (2017)

The CoGenT3 Study: Cognition and Gender Trends in Three American Generations
por: Stites, Shana
Publicado: (2020)

Intersections of Gender and Cognition in Older Adults
por: Stites, Shana, et al.
Publicado: (2020)

Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
por: Harkins, Kristin, et al.
Publicado: (2015)

Study partners should be required in preclinical Alzheimer’s disease trials
por: Grill, Joshua D., et al.
Publicado: (2017)

Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials
por: Grill, Joshua D, et al.
Publicado: (2010)

Stigma: how it affects the substance use disorder patient
por: Zwick, Janet, et al.
Publicado: (2020)

Using a Mediator's Toolbox: Reducing Clinical Conflict by Learning to Reconceive the “Difficult” Patient or Family
por: Fiester, Autumn, et al.
Publicado: (2023)

Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society
por: Erickson, Claire M., et al.
Publicado: (2022)

How useful are biomarkers for the diagnosis of Alzheimer’s disease and especially for its therapy?
por: Valenza, Marta, et al.
Publicado: (2022)

Memory Awareness Influences Everyday Decision Making Capacity about Medication Management in Alzheimer's Disease
por: Cosentino, Stephanie, et al.
Publicado: (2011)

How to identify mushrooms to genus I : macroscopic features /
por: Largent, David L.
Publicado: (1986)

APOE ε4, an Alzheimer’s disease susceptibility allele, and smoking cessation
por: Ashare, Rebecca L., et al.
Publicado: (2012)

Biomarkers for Alzheimer’s Disease Diagnosis
por: Mantzavinos, Vasileios, et al.
Publicado: (2017)

Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment
por: Christensen, Kurt D., et al.
Publicado: (2020)

A Narrative Review of Alzheimer’s Disease Stigma
por: Rosin, Eric R., et al.
Publicado: (2020)

African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials
por: Zhou, Yan, et al.
Publicado: (2016)

EXPERIENCES OF INNER STRENGTH AT THE TIME OF MILD COGNITIVE IMPAIRMENT DIAGNOSIS
por: Morgan, Brianna, et al.
Publicado: (2022)

How Perceptions of HIV-Related Stigma Affect Decision-Making Regarding Childbirth in Rural Kenya
por: Medema-Wijnveen, José S., et al.
Publicado: (2012)

Contributions of neighborhood social environment and air pollution exposure to Black-White disparities in epigenetic aging
por: Yannatos, Isabel, et al.
Publicado: (2023)

Weight Stigma Affects Men Too
por: Pearl, Rebecca L., et al.
Publicado: (2018)

How Anticipated and Experienced Stigma Can Contribute to Self-Stigma: The Case of Problem Gambling
por: Hing, Nerilee, et al.
Publicado: (2017)

Examining stigma relating to substance use and contextual factors in social media discussions
por: Chen, Annie T., et al.
Publicado: (2022)

Diagnosis and biomarkers of predementia in Alzheimer's disease
por: Forlenza, Orestes V, et al.
Publicado: (2010)

CSF Biomarkers for Alzheimer's Disease Diagnosis
por: Anoop, A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_742l4p32hahbtcikesj1lcuqev